Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU

Sandra L. Kane-Gill; Joseph F. Dasta; Mitchell S. Buckley; Sandeep Devabhakthuni; Michael Liu; Henry Cohen; Elizabeth L. George; Anne S. Pohlman; Swati Agarwal; Elizabeth A. Henneman; Sharon M. Bejian; Sean M. Berenholtz; Jodie L. Pepin; Mathew C. Scanlon; Brian S. Smith

doi:10.1097/CCM.0000000000002519

Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU

Sandra L. Kane-Gill, Joseph F. Dasta, Mitchell S. Buckley, Sandeep Devabhakthuni, Michael Liu, Henry Cohen, Elizabeth L. George, Anne S. Pohlman, Swati Agarwal, Elizabeth A. Henneman, Sharon M. Bejian, Sean M. Berenholtz, Jodie L. Pepin, Mathew C. Scanlon, Brian S. Smith

School of Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.

Original language	English (US)
Pages (from-to)	1546-1551
Number of pages	6
Journal	Critical care medicine
Volume	45
Issue number	9
DOIs	https://doi.org/10.1097/CCM.0000000000002519
State	Published - Sep 1 2017

Keywords

critical care intensive care unit
drug-related side effects and adverse reactions
medication errors
patient safety
safety management

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine

Access to Document

10.1097/CCM.0000000000002519

Cite this

Kane-Gill, S. L., Dasta, J. F., Buckley, M. S., Devabhakthuni, S., Liu, M., Cohen, H., George, E. L., Pohlman, A. S., Agarwal, S., Henneman, E. A., Bejian, S. M., Berenholtz, S. M., Pepin, J. L., Scanlon, M. C., & Smith, B. S. (2017). Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU. Critical care medicine, 45(9), 1546-1551. https://doi.org/10.1097/CCM.0000000000002519

Kane-Gill, SL, Dasta, JF, Buckley, MS, Devabhakthuni, S, Liu, M, Cohen, H, George, EL, Pohlman, AS, Agarwal, S, Henneman, EA, Bejian, SM, Berenholtz, SM, Pepin, JL, Scanlon, MC & Smith, BS 2017, 'Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU', Critical care medicine, vol. 45, no. 9, pp. 1546-1551. https://doi.org/10.1097/CCM.0000000000002519

@article{dcf9a97ac53c4b09a42b25272ccfe7d1,

title = "Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU",

abstract = "This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.",

keywords = "critical care intensive care unit, drug-related side effects and adverse reactions, medication errors, patient safety, safety management",

author = "Kane-Gill, {Sandra L.} and Dasta, {Joseph F.} and Buckley, {Mitchell S.} and Sandeep Devabhakthuni and Michael Liu and Henry Cohen and George, {Elizabeth L.} and Pohlman, {Anne S.} and Swati Agarwal and Henneman, {Elizabeth A.} and Bejian, {Sharon M.} and Berenholtz, {Sean M.} and Pepin, {Jodie L.} and Scanlon, {Mathew C.} and Smith, {Brian S.}",

year = "2017",

month = sep,

day = "1",

doi = "10.1097/CCM.0000000000002519",

language = "English (US)",

volume = "45",

pages = "1546--1551",

journal = "Critical care medicine",

issn = "0090-3493",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Executive Summary

T2 - Clinical Practice Guideline: Safe Medication Use in the ICU

AU - Kane-Gill, Sandra L.

AU - Dasta, Joseph F.

AU - Buckley, Mitchell S.

AU - Devabhakthuni, Sandeep

AU - Liu, Michael

AU - Cohen, Henry

AU - George, Elizabeth L.

AU - Pohlman, Anne S.

AU - Agarwal, Swati

AU - Henneman, Elizabeth A.

AU - Bejian, Sharon M.

AU - Berenholtz, Sean M.

AU - Pepin, Jodie L.

AU - Scanlon, Mathew C.

AU - Smith, Brian S.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.

AB - This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.

KW - critical care intensive care unit

KW - drug-related side effects and adverse reactions

KW - medication errors

KW - patient safety

KW - safety management

UR - http://www.scopus.com/inward/record.url?scp=85032358778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032358778&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000002519

DO - 10.1097/CCM.0000000000002519

M3 - Article

C2 - 28816838

AN - SCOPUS:85032358778

SN - 0090-3493

VL - 45

SP - 1546

EP - 1551

JO - Critical care medicine

JF - Critical care medicine

IS - 9

ER -

Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this